Terns Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Terns Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Terns Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.38M, a 105% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.38M +$705K +105% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $217K -$539K -71.3% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $369K -$532K -59% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $523K -$524K -50% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $671K -$523K -43.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $756K -$489K -39.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $901K -$475K -34.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.05M +$1.05M Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1.19M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.25M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.38M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.